Provided herein, in some embodiments, are rapid diagnostic tests comprising a lateral flow strip and an integrated swab head. The tests may be used to detect, for example, one or more pathogens, such as viral, bacterial, fungal, parasitic, or protozoan pathogens. Further embodiments provide methods of detecting genetic abnormalities. Nucleic acid tests using the diagnostic tests are provided.

A method of taking a skin sample can include placing an adhesive onto a portion of skin and lifting the adhesive from the skin. A skin sample may then be tested while still on the adhesive, for example, by inoculating the sample with a bacterium, fungus, virus, or a combination.

A method for managing an immune pass includes receiving uploaded immunization data for at least one individual, wherein the immunization data comprises data indicating antibody levels for a particular virus. The method also includes analyzing the immunization data to determine an immune pass status for the at least one individual and generating an immune pass for the at least one individual, wherein the immune pass includes the immune pass status and personal identifiable information for the at least one individual. The method further includes storing the immune pass, verifying a request to retrieve the immune pass corresponding to the at least one individual, and transmitting the immune pass in response to verification of the request.

A method for managing an immune pass includes receiving uploaded immunization data for at least one individual, wherein the immunization data comprises data indicating antibody levels for a particular virus. The method also includes analyzing the immunization data to determine an immune pass status for the at least one individual and generating an immune pass for the at least one individual, wherein the immune pass includes the immune pass status and personal identifiable information for the at least one individual. The method further includes storing the immune pass, verifying a request to retrieve the immune pass corresponding to the at least one individual, and transmitting the immune pass in response to verification of the request.

A method is provided that includes rinsing an oral cavity of a subject with a rinse liquid. Thereafter, a gargle liquid is introduced into the oral cavity and gargled by the subject. Thereafter, at least a portion of the gargled liquid is collected as a specimen sample. Other embodiments are also described.

Provided is a device for detecting airborne particulate matter in aerosols, comprising: an air sampler to collect a sample of airborne particles suspended in air; an optical sensor; a controller; a fluidic apparatus to, under the control of the controller: capture, from the air sampler, and resuspend in a liquid medium, at least part of the airborne particles of the sample; and deliver the resuspended airborne particles to the optical sensor, which is configured to detect airborne particulate matter in the delivered airborne particles.

Also provided is a method adapted to use the device of the invention, and to a computer program product adapted to implement the method of the invention.

The present disclosure relates to an electrochemical sensor, which employ fluoro organothiol or fluoro organosilane molecules in the formation of self-assembled monolayer (SAM) for use in diagnosis tests. There is also provided methods of testing a patient sample using the electrochemical sensor as disclosed.

Provided is a novel neutralizing antibody against spike protein of SARS-COV-2, and the antigen binding fragments thereof. Pharmaceutical composition and kits comprising the same, and the uses thereof are also provided.

The present invention relates to a method for assessing the severity of Severe Acute Respiratory Syndrome (SARS) in a patient; said method being based on a severity score consisting of at least: a) a respiratory system score, b) a score determined by the level of pancreatic stone protein/regenerating protein (PSP/reg) in a body fluid sample from said patient. The invention may be used in a healthcare unit for sorting patients to decide the treatment priority

A method is provided with which biomolecules (5) such as viruses, for example, are quantitatively determined and/or separated very rapidly. Antigens or receptors (2) are directly or indirectly fixed so closely together on a substrate (1) that they couple together in phase. A dynamic charge displacement field is significantly increased compared to a single antigen or receptor (2) by means of the phase coupling, so that biomolecules (5) which are located in the range of the larger charge displacement field move immediately in the direction of the phase-coupled antigens or receptors (2). The binding kinetics are significantly faster than in the case of conventional methods. The invention enables, for example, the construction of a rapid test for coronavirus which can deliver a result within seconds. The sensitivity which can be obtained is that of one virus. The method can be applied to liquids (6) or aerosols (7).